14,986 CVS Health Corporation $CVS Shares Sold by Commonwealth Equity Services LLC

Key Points

• Commonwealth Equity Services cut its CVS stake by 4.3%, selling 14,986 shares in the third quarter; it ended the period with 331,321 shares valued at about $28.4 million.
• CVS beat third-quarter earnings and revenue expectations, reporting EPS of $2.09 versus $1.65 expected and revenue of $108.4 billion. The company also raised its 2026 outlook.
• Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%; analysts’ consensus rating is “Moderate Buy,” with a $108.25 target price.

Commonwealth Equity Services LLC lessened its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 4.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 331,321 shares of the pharmacy operator's stock after selling 14,986 shares during the quarter. Commonwealth Equity Services LLC's holdings in CVS Health were worth $28,391,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. Kilter Group LLC bought a new position in shares of CVS Health during the second quarter valued at $27,000. J.Safra Asset Management Corp acquired a new position in shares of CVS Health during the second quarter worth $30,000. Beaird Harris Wealth Management LLC lifted its holdings in shares of CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator's stock worth $30,000 after purchasing an additional 195 shares during the period. Timbuktu Capital Management LLC bought a new stake in shares of CVS Health in the second quarter worth $31,000. Finally, Dunhill Financial LLC bought a new stake in shares of CVS Health in the second quarter worth $32,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Price Performance

Shares of NYSE:CVS opened at $83.76 on Monday. The firm has a market capitalization of $107.17 billion, a PE ratio of 9.75, a P/E/G ratio of 0.73 and a beta of 0.58. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The company has a 50-day moving average price of $90.37 and a two-hundred day moving average price of $88.89. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.65 by $0.44. The company had revenue of $108.40 billion for the quarter, compared to analyst estimates of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The company's quarterly revenue was up 5.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.60 earnings per share. Equities analysts forecast that CVS Health Corporation will post 8.25 EPS for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were issued a dividend of $0.6650 per share. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.2%. CVS Health's payout ratio is presently 30.97%.

Insider Activity

In related news, EVP Prem Shah bought 23,855 shares of the company's stock in a transaction on Friday, November 6th. The shares were purchased at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the transaction, the executive vice president directly owned 88,516 shares in the company, valued at approximately $7,425,607.24. The trade was a 36.89% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.85% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on CVS shares. Wall Street Zen downgraded CVS Health from a "strong-buy" rating to a "buy" rating in a report on Monday, October 19th. Robert W. Baird set a $107.00 target price on CVS Health in a report on Thursday, August 6th. TD Cowen reiterated a "buy" rating on shares of CVS Health in a research report on Wednesday. UBS Group decreased their price target on CVS Health from $118.00 to $107.00 and set a "buy" rating for the company in a research note on Thursday. Finally, Barclays decreased their price target on CVS Health from $108.00 to $107.00 and set an "overweight" rating for the company in a research note on Thursday. Twenty-two analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, CVS Health has a consensus rating of "Moderate Buy" and a consensus target price of $108.25.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
• Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
• Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
• Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
• Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage

CVS Health Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.